Results 41 to 50 of about 1,296 (168)
ClinicoEconomics and Outcomes Research, 2015 Bernice Tsoi,1,2 Gord Blackhouse,1,2 Simon Ferrazzi,3 Clare J Reade,4 Innie Chen,5,6 Ron Goeree1,2,7 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 2Programs for Assessment of Technology in Health (PATH)
Tsoi B +5 more
doaj
Empowering organ-preserving treatment of uterine fibroids using ulipristal acetate [PDF]
Гинекология, 2016 The choice of treatment of uterine leiomyoma affects different factors: the intensity of the symptoms of fibroids characteristics, age and the need for preservation of the uterus (and fertility).
A L Tikhomirov
doaj
Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 6, Page 1172-1180, June 2025.MR‐HIFU can offer rapid and sustainable symptom relief for selected symptomatic fibroid patients. The severity of fibroid‐related symptoms was significantly reduced at 3 and 12 months, while the quality of life had increased. In addition, the treatment can be offered to women planning future pregnancies, as no negative effect on future fertility or ...
Saara Otonkoski +7 more
wiley +1 more source
Медицинский совет, 2019 The leading role of ovarian steroid hormones in the pathogenesis of uterine fibroids is confirmed by epidemiological, clinical and experimental studies.
E. R. Dovletkhanova +2 more
doaj +1 more source
Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span
Frontiers in Medicine, 2020 Background: When choosing a surgical procedure for a hysterectomy, doctors and patients have various options in terms of the multiple surgical access points available.
Florian Ebner +8 more
doaj +1 more source
Haemophilia, Volume 31, Issue 3, Page 485-493, May 2025.ABSTRACT Introduction Heavy menstrual bleeding (HMB) is a common presenting symptom in women with bleeding disorders, yet haemostatic testing is sometimes overlooked, even when refractory HMB requires surgical intervention. Aim To determine the prevalence of bleeding disorders in women referred for surgical management of HMB and investigate screening ...
Alison Delaney +8 more
wiley +1 more source
Ulipristal acetate in uterine fibroids treatment
Гинекология, 2013 Ulipristal acetate is a selective progesterone receptor modulator, characterized by partial tissue-specific antiprogesteron effect, which is used in order to prepare uterine cancer patients for surgery.
V V Korennaya, N M Podzolkova
doaj
Menopause Review, 2014 Aim of the study: The purpose of the study was to monitor the effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up.
Sławomir Woźniak +6 more
doaj +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 4, Page 518-528, March 2025.ABSTRACT Objective We aim to clarify potential risk factors of complications after uterine artery embolisation (UAE). Setting Complications after uterine artery embolisation (UAE) for symptomatic fibroids are rare, but failure of treatment occurs for approximately 13%–24% of patients at 10 years.
Adeline de Wit +3 more
wiley +1 more source